Serge Beaulieu, MD, PhD, FRCPC

Department of Psychiatry, McGill University, Montreal, Quebec, Canada; Douglas Mental Health University Institute, McGill University, Verdun, Quebec, Canada; Bipolar Disorders Clinic, Douglas Mental Health University Institute, McGill University, Verdun, Quebec, Canada

  • 3Articles
  • 14.6KReads
  • 2001–2025Active
  • 46Collaborators
  • 117Citations

About

Serge Beaulieu, MD, PhD, FRCPC is affiliated with Department of Psychiatry, McGill University, Montreal, Quebec, Canada; Douglas Mental Health University Institute, McGill University, Verdun, Quebec, Canada; Bipolar Disorders Clinic, Douglas Mental Health University Institute, McGill University, Verdun, Quebec, Canada. Serge Beaulieu has authored or co-authored 3 peer-reviewed articles published across the Journal of Clinical Psychiatry and the Primary Care Companion for CNS Disorders between 2001 and 2025. Their work focuses on Bipolar Disorder, Depression (MDD), and Weight.

Publications

JCP
Artificial Intelligence in Depression – Medication Enhancement (AID-ME): A Cluster Randomized Trial of a Clinical Decision Support System for Personalized Depression Treatment Selection and Management
Original Research

Artificial Intelligence in Depression – Medication Enhancement (AID-ME): A Cluster Randomized Trial of a Clinical Decision Support System for Personalized Depression Treatment Selection and Management

August 27, 2025

This study provides preliminary evidence that longitudinal use of an AI-enabled clinical decision support system can improve outcomes in MDD.
, , , et al
JCP
Article

A Randomized Controlled Trial of Psychoeducation or Cognitive-Behavioral Therapy in Bipolar Disorder: A Canadian Network for Mood and Anxiety Treatments (CANMAT) Study

June 15, 2012

, , , et al
JCP
Letter to the Editor

Body Weight Gain, Insulin, and Leptin in Olanzapine-Treated Patients

November 1, 2001

,

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe